The ADAPT study will evaluate the safety and effectiveness of the company's Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System "This FDA approval to initiate our ADAPT study marks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback